1Stahl W, Sies H. Lycopene: a biologically important carotenoid for humans[ J]. Arch Bioehem Biophys, 1996,336(1):1-9.
2Kohlmeier L, Kark JD, Gomez-Gracia E, at al. Lycopene and myocardial infarction risk in the EURAMIC Study[J]. Am J Epidemiol, 1997,146(8) :618-626.
3Klipstein-Grobusch K, Launer LJ, Geleijnse JM, et al. Serum carotenoids and atherosclerosis. The Rotterdam Study [J]. Atherosclerosis,2000,148(1) :49-56.
4Rissanen T, Voutilainen S, Nyyssonen K, et al. Low plasma lycopene concentration is associated with increased intima-media thickness of the carotid arlery wall[J]. Artefioscler Thromb Vase Biol,2000,20(12) :2677-2681.
5Rissanen TH, Voutilainen S, Nyyssonen K, et al. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Isehaemie Heart Disease Risk Factor Study[J]. Br J Nutr.2001.85(6):749-754.
6Suganuma H, Inakuma T. Protective effect of dietary tomato against endothelial dysfunction in hypercholesterolemie miee[J]. Biosci Biotechnol Bioehem, 1999,63(1):78-82.
7Mortensen A,Skibsted LH , Sampson J, et al. Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidant[J].FEBS Lett,1997,418(1-2):91-97.
8Ford ES, Will JC, Bowman BA, et al. Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey[J]. Am J Epidemiol, 1999,149(2):168-176.
9Jang Y, Lee JH, Kim OY, et al. Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial[J]. Arterioscler Thromb Vasc Biol,2001,21(12) :2065-2071.
10Upfitchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes[J] . Diabetes Care, 2000,23(6) :733-738.
